英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

请选择你想看的字典辞典：

单词	字典	翻译
alector	查看　alector　在百度字典中的解释	百度英翻中〔查看〕
alector	查看　alector　在Google字典中的解释	Google英翻中〔查看〕
alector	查看　alector　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://www.51zidian.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.51zidian.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Alector Therapeutics for Neurodegenerative Disease
Alector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases
Pipeline for Neurodegenerative Diseases - Alector
Our pipeline provides an overview of our late-stage clinical development programs for neurodegenerative diseases
About Us - Alector
Alector is on a mission to erase neurodegenerative diseases We exist to restore the experience of life for patients, caregivers, and families
Investors | Alector
The Investor Relations website contains information about Alector's business for stockholders, potential investors, and financial analysts
Our Executive Leadership Board of Directors - Alector
Alector is led by a seasoned team of inventors, scientists, and big thinkers We combine our deep expertise to deliver life-transforming medicines
Our History Overview - Alector
Alector was founded in 2013 Read through our history and highlights along the way from our journey in developing neurodegeneration medication
Alector Announces Topline Results from Latozinemab Phase 3 Trial in . . .
SOUTH SAN FRANCISCO, Calif , Oct 21, 2025 (GLOBE NEWSWIRE) -- Alector, Inc (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced results from the Phase 3 INFRONT-3 clinical trial
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical . . .
The trial, being conducted in partnership with GSK, is expected to enroll approximately 282 patients globally SOUTH SAN FRANCISCO, Calif , Feb 08, 2024 (GLOBE NEWSWIRE) -- Alector, Inc (Nasdaq: ALEC) and GSK plc (LSE NYSE: GSK) today announced that the first patient has been dosed in PROGRESS-AD, the global Phase 2 clinical trial of AL101 GSK4527226 in patients with early Alzheimer’s
Alector Reports Second Quarter 2024 Financial Results and Provides . . .
Alector’s management team will host a conference call discussing Alector’s results for the second quarter of 2024 and provide a business update The conference call will be webcast and accessible via the investor relations section of Alector’s website at www alector com To access the call, please use the following information:

中文字典-英文字典 2005-2009